Literature DB >> 3035211

Posttranslational processing of the Epstein-Barr virus-encoded p63/LMP protein.

K P Mann, D Thorley-Lawson.   

Abstract

In this paper we describe the posttranslational processing of the p63/LMP (latent membrane protein) encoded by Epstein-Barr virus in transformed B cells. Specifically, we show that after synthesis, free LMP disappeared with a half-life of about 0.5 h. This was caused by the association of LMP with an insoluble complex. All detectable LMP in the plasma membrane was insoluble. This interaction was resistant to nondenaturing detergents but readily dissociated with 8 M urea or by boiling in 0.5% sodium dodecyl sulfate, suggesting that LMP may be associated with cytoskeletal elements. Most of the Nonidet P-40-insoluble LMP was phosphorylated (ppLMP) primarily on serine but also on threonine residues. No phosphotyrosine was detected. Furthermore, greater than 90% of the ppLMP resided in the Nonidet P-40-insoluble fraction, suggesting a strong correlation between complexing and phosphorylation. Additionally, ppLMP was found to be associated with a 53,000-molecular-weight phosphoprotein (pp53) of unknown origin. Finally, LMP turned over extremely rapidly, with a half-life of about 2 h. Taken together, these properties suggest that although LMP falls broadly within the category of phosphorylated, cytoskeleton-associated oncoproteins, it is nevertheless clearly different from any previously described member of this family.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3035211      PMCID: PMC254230          DOI: 10.1128/JVI.61.7.2100-2108.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Rapid isolation of antigens from cells with a staphylococcal protein A-antibody adsorbent: parameters of the interaction of antibody-antigen complexes with protein A.

Authors:  S W Kessler
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

Review 2.  Solubilization of membranes by detergents.

Authors:  A Helenius; K Simons
Journal:  Biochim Biophys Acta       Date:  1975-03-25

3.  Cytoskeletal elements of chick embryo fibroblasts revealed by detergent extraction.

Authors:  S Brown; W Levinson; J A Spudich
Journal:  J Supramol Struct       Date:  1976

Review 4.  Preparation and properties of lymphocyte plasma membrane.

Authors:  M J Crumpton; D Snary
Journal:  Contemp Top Mol Immunol       Date:  1974

5.  Amino-terminal sequence analysis of proteins purified on a nanomole scale by gel electrophoresis.

Authors:  A M Weiner; T Platt; K Weber
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis.

Authors:  G Henle; W Henle; V Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

8.  The detertent-resistant cytoskeleton of tissue culture cells includes the nucleus and the microfilament bundles.

Authors:  M Osborn; K Weber
Journal:  Exp Cell Res       Date:  1977-05       Impact factor: 3.905

Review 9.  Intracellular protein degradation in mammalian and bacterial cells: Part 2.

Authors:  A L Goldberg; A C St John
Journal:  Annu Rev Biochem       Date:  1976       Impact factor: 23.643

10.  Establishment of lines from normal human blood leukocytes by co-cultivation with a leukocyte line derived from a leukemic child.

Authors:  G Miller; J F Enders; H Lisco; H I Kohn
Journal:  Proc Soc Exp Biol Med       Date:  1969-10
View more
  24 in total

1.  The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling.

Authors:  K D Erickson; J M Martin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.

Authors:  Jingwu Xu; Ali Ahmad; José Menezes
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells.

Authors:  D Liebowitz; J Mannick; K Takada; E Kieff
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

4.  Epstein-Barr virus latent membrane protein 1 (LMP-1) half-life in epithelial cells is down-regulated by lytic LMP-1.

Authors:  Jyotsna Pandya; Dennis M Walling
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

5.  The Epstein-Barr virus-encoded LMP-1 oncoprotein negatively affects Tyk2 phosphorylation and interferon signaling in human B cells.

Authors:  Timothy R Geiger; Jennifer M Martin
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

6.  Virus and cell RNAs expressed during Epstein-Barr virus replication.

Authors:  Jing Yuan; Ellen Cahir-McFarland; Bo Zhao; Elliott Kieff
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP.

Authors:  R Moorthy; D A Thorley-Lawson
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

9.  Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.

Authors:  M Sandberg; W Hammerschmidt; B Sugden
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

10.  LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation.

Authors:  Frederik J Verweij; Monique A J van Eijndhoven; Erik S Hopmans; Tineke Vendrig; Tom Wurdinger; Ellen Cahir-McFarland; Elliott Kieff; Dirk Geerts; Rik van der Kant; Jacques Neefjes; Jaap M Middeldorp; D Michiel Pegtel
Journal:  EMBO J       Date:  2011-04-28       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.